Videos
Tackling the Global Issue of Ancestral Disparities in Alzheimer Disease: Margaret Pericak-Vance, PhD
July 21st 2022The director of the John P. Hussman Institute for Human Genomics at the University of Miami discussed the background behind a new initiative geared towards understanding genetic differences of underrepresented groups. [WATCH TIME: 6 minutes]
Fostering Patient-Centered Care in Ethnically Diverse, Underrepresented MS Patients
July 21st 2022Jeffrey Dunn, MD, and Regina Berkovich, MD, PhD, highlight the role of a multidisciplinary care team in engaging ethnically diverse and underrepresented patient populations with multiple sclerosis in clinical trials and practice.
The Treatment of Status Migrainosus in Emergency Care Settings: Matthew Robbins, MD
July 20th 2022The neurologist at Weill Cornell Medicine and NewYork-Presbyterian Hospital offered his insight into the state of treatment for status migrainosus and whether or not the new migraine medications can help improve care. [WATCH TIME: 2 minutes]
The Need for More Time in Movement Disorder Care: Temitope Lawal, MD
July 19th 2022The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center spoke about the need for clinicians to have more time with patients in clinical practice, particularly with those with chronic diseases. [WATCH TIME: 2 minutes]
Feasibility and Limitations of Exoskeletons for Multiple Sclerosis Rehab: Francois Bethoux, MD
July 18th 2022The chair of Cleveland Clinic’s Department of Physical Medicine provided background on the usage of exoskeletons in the clinical and at-home settings for rehabbing patients with multiple sclerosis. [WATCH TIME: 2 minutes]
Expanding Genetic Associations Between Races and Alzheimer Disease: Margaret Pericak-Vance, PhD
July 18th 2022The director of the John P. Hussman Institute for Human Genomics at the University of Miami discussed non-APOE–related genetic correlations between different groups of individuals and Alzheimer disease. [WATCH TIME: 5 minutes]
Technological Advancements Improving, Expanding Capabilities of Antibody Testing: Sean Pittock, MD
July 17th 2022The director of the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology discussed the technological capabilities the center has, including the improved use of neural antibody testing. [WATCH TIME: 6 minutes]
The Role of Genetics in Alzheimer Drug Development: Margaret Pericak-Vance, PhD
July 15th 2022The director of the John P. Hussman Institute for Human Genomics at the University of Miami provided insight on the outlook on genetics and gene-based therapies for Alzheimer disease. [WATCH TIME: 3 minutes]
Bridget A. Bagert, MD, and Ahmed Obeidat, MD, PhD, examine the clinical implications of a causal link between Epstein-Barr virus and multiple sclerosis and provide insight on how to discuss this link with patients.
Investigations Into the Causal Link Between EBV and MS
Lawrence Steinman, MD, discusses his recent publication, which demonstrated the causal link between Epstein-Barr virus and multiple sclerosis, highlighting key findings and conclusions.
Realistic Expectations and Limitations in MS Rehab With Exoskeletons: Francois Bethoux, MD
July 14th 2022The chair of Cleveland Clinic’s Department of Physical Medicine discussed the different ways a newly approved robotic exoskeleton can improve gait in patients with multiple sclerosis. [WATCH TIME: 4 minutes]
Drawing From Experience When Treating Parkinson Disease: Temitope Lawal, MD
July 14th 2022The neurologist and movement disorders fellow at University Hospitals Cleveland Medical Center spoke about how his experience as a caregiver shapes his perspective as a doctor in care for those with movement disorders. [WATCH TIME: 3 minutes]
